statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.390
GB - Regno Unito	293
SG - Singapore	168
CN - Cina	159
IT - Italia	136
HK - Hong Kong	123
VN - Vietnam	79
SE - Svezia	62
DE - Germania	54
BR - Brasile	52
FI - Finlandia	37
RU - Federazione Russa	29
FR - Francia	23
UA - Ucraina	23
KR - Corea	14
TR - Turchia	14
CA - Canada	13
ID - Indonesia	10
IN - India	10
MX - Messico	10
BG - Bulgaria	9
BD - Bangladesh	8
BE - Belgio	8
JP - Giappone	8
IQ - Iraq	7
ES - Italia	6
PL - Polonia	6
AR - Argentina	5
AU - Australia	4
CZ - Repubblica Ceca	4
MA - Marocco	4
PK - Pakistan	4
RO - Romania	4
ZA - Sudafrica	4
AE - Emirati Arabi Uniti	3
IE - Irlanda	3
JM - Giamaica	3
NL - Olanda	3
PH - Filippine	3
VE - Venezuela	3
AZ - Azerbaigian	2
BZ - Belize	2
DK - Danimarca	2
HN - Honduras	2
KG - Kirghizistan	2
KZ - Kazakistan	2
TN - Tunisia	2
BH - Bahrain	1
CL - Cile	1
CR - Costa Rica	1
CY - Cipro	1
DZ - Algeria	1
EC - Ecuador	1
ET - Etiopia	1
HR - Croazia	1
IL - Israele	1
KW - Kuwait	1
LT - Lituania	1
LV - Lettonia	1
MY - Malesia	1
PE - Perù	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
Totale	2.831

Nome	#
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation	582
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells	350
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide	324
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells.	315
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia	291
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia	285
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS	263
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.	228
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia	214
Totale	2.852

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	47	0	0	0	0	0	0	0	0	0	20	10	17
2021/2022	171	13	24	9	9	5	15	9	10	14	11	38	14
2022/2023	207	19	28	16	18	26	30	3	24	21	3	7	12
2023/2024	128	2	6	7	17	21	20	12	12	0	1	13	17
2024/2025	454	8	13	4	30	62	57	33	29	89	14	48	67
2025/2026	874	78	42	56	113	179	76	125	31	96	78	0	0
Totale													2.852